CYCLO THERAPEUTICS, INC. Financing Receivable, after Allowance for Credit Loss, Current
CYCLO THERAPEUTICS, INC. had Financing Receivable, after Allowance for Credit Loss, Current of $0 as of 2022-12-31, per its 10-K filed 2023-03-17.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts and Financing Receivable, after Allowance for Credit Loss, Current
us-gaap:NotesAndLoansReceivableNetCurrent · last filed 2023-03-17
- 2022-12-31: Financing Receivable, after Allowance for Credit Loss, Current $0.00.
- 2022-09-30: Financing Receivable, after Allowance for Credit Loss, Current $0.00.
- 2022-06-30: Financing Receivable, after Allowance for Credit Loss, Current $28.76K.
- 2022-03-31: Financing Receivable, after Allowance for Credit Loss, Current $39.34K.
| Period end | Financing Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-17 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 |
| 2022-06-30 | $28.76K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $39.34K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $45.98K 10-K · filed 2023-03-17 |
| 2021-09-30 | $45.07K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $42.05K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $48.30K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $40.77K 10-K · filed 2022-03-11 |
| 2020-09-30 | $39.06K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $39.06K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $39.06K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $39.06K 10-K · filed 2021-03-12 |
| 2019-09-30 | $37.44K 10-Q · filed 2019-11-14 |
| 2018-12-31 | $37.44K 10-K · filed 2020-03-30 |